Evidence map›Paper›PMID 29789978›Full record

ArticleAMB Express2018

Diauxic growth of Clostridium acetobutylicum ATCC 824 when grown on mixtures of glucose and cellobiose.

Felipe Buendia-Kandia, Emmanuel Rondags, Xavier Framboisier, Guillain Mauviel, Anthony Dufour, Emmanuel Guedon

Abstract read
In one paragraph

Article in AMB Express, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Felipe Buendia-KandiaLRGP, UMR CNRS 7274, Université de Lorraine, 2 Avenue de la Forêt de Haye TSA 40602, 54518, Vandoeuvre lès Nancy, France.
Emmanuel RondagsLRGP, UMR CNRS 7274, Université de Lorraine, 2 Avenue de la Forêt de Haye TSA 40602, 54518, Vandoeuvre lès Nancy, France.
Xavier FramboisierLRGP, UMR CNRS 7274, Université de Lorraine, 2 Avenue de la Forêt de Haye TSA 40602, 54518, Vandoeuvre lès Nancy, France.
Guillain MauvielLRGP, UMR CNRS 7274, Université de Lorraine, 1 Rue Grandville, 54000, Nancy, France.
Anthony DufourLRGP, UMR CNRS 7274, Université de Lorraine, 1 Rue Grandville, 54000, Nancy, France.
Emmanuel GuedonLRGP, UMR CNRS 7274, Université de Lorraine, 2 Avenue de la Forêt de Haye TSA 40602, 54518, Vandoeuvre lès Nancy, France. Emmanuel.Guedon@univ-lorraine.fr.ORCID http://orcid.org/0000-0001-8758-3779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridium acetobutylicum, a promising organism for biomass transformation, has the capacity to utilize a wide variety of carbon sources. During pre-treatments of (ligno) cellulose through thermic and/or enzymatic processes, complex mixtures of oligo saccharides with beta 1,4-glycosidic bonds can be produced. In this paper, the capability of C. acetobutylicum to ferment glucose and cellobiose, alone and in mixtures was studied. Kinetic studies indicated that a diauxic growth occurs when both glucose and cellobiose are present in the medium. In mixtures, D-glucose is the preferred substrate even if cells were pre grown with cellobiose as the substrate. After the complete consumption of glucose, the growth kinetics exhibits an adaptation time, of few hours, before to be able to use cellobiose. Because of this diauxic phenomenon, the nature of the carbon source deriving from a cellulose hydrolysis pre-treatment could strongly influence the kinetic performances of a fermentation process with C. acetobutylicum.

Indexed as

BiomassCellobioseCelluloseClostridium acetobutylicumDiauxieFermentation

Identifiers

PMID29789978
PMCPMC5964051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.